Results 101 to 110 of about 274,722 (228)
Adjuvanted Immunotherapy Approaches for Peanut Allergy
Food allergies are a growing public health concern with an estimated 8% of US children affected. Peanut allergies are also on the rise and often do not spontaneously resolve, leaving individuals at-risk for potentially life-threatening anaphylaxis ...
Brandi T. Johnson-Weaver +7 more
doaj +1 more source
Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy
IgE-mediated food allergies are caused by adverse immunologic responses to food proteins. Allergic reactions may present locally in different tissues such as skin, gastrointestinal and respiratory tract and may result is systemic life-threatening ...
Ann-Marie Malby Schoos +34 more
doaj +1 more source
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells [PDF]
Epicutaneous application of Aldara cream containing the TLR7 agonist imiquimod (IMQ) to mice induces skin inflammation that exhibits many aspects of psoriasis, an inflammatory human skin disease.
A Johnston +62 more
core +2 more sources
Emerging Frontiers in Food Allergy Treatment: Progress, Challenges, and Prospects
Food allergy is a rising global health concern with limited treatment options beyond allergen avoidance and emergency care. This review explores the evolving therapeutic landscape, highlighting advances in allergen immunotherapy, biologics such as monoclonal antibodies, and emerging vaccine‐based approaches.
Ayesha Zahid +3 more
wiley +1 more source
This randomised controlled trial of peanut oral immunotherapy (pOIT) in preschool children found that 12 months of low dose pOIT was effective at inducing desensitisation in 74% of children receiving pOIT (vs 11% of children avoiding peanut) and was associated with better quality of life than avoidance.
Michael O'Sullivan +9 more
wiley +1 more source
IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy. [PDF]
IL-6 plays a central role in supporting pathological TH2 and TH17 cell development and inhibiting the protective T regulatory cells in allergic asthma. TH17 cells have been demonstrated to regulate allergic asthma in general and T-bet-deficiency-induced ...
Finotto, S. +9 more
core +2 more sources
Oral and Skin Sensitisation to Peanut Show Different Immunological Features in Brown Norway Rats
Immunological features differ between oral and skin sensitisation, with oral and skin sensitisation driving the development of IgE to different major allergens in peanut, which could pave the way for determining the sensitisation route in patients. Further, oral and skin sensitisation promote different immunological responses in the intestine, which ...
Tiffany K. S. Sztuk +7 more
wiley +1 more source
Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy
The prevalence of allergic diseases, including food allergy, is increasing, especially in developed countries. Implementation of an elimination diet is not a sufficient therapeutic strategy in patients with food allergy, whose quality of life is ...
Mirjana Turkalj +3 more
doaj +1 more source
We used patient samples and a murine model to understand the contribution of Bregs to EoE immunopathology. We find that Breg‐derived IL‐10 is important for controlling EoE, but that Breg expansion and function are impaired in this condition. We identify IFNγ as a key negative regulator of Breg function in mice and patients with EoE. Bregs, regulatory B
Rachel L. Clement +4 more
wiley +1 more source
New modalities of allergen immunotherapy
Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and ...
Manish Ramesh, Merhunisa Karagic
doaj +1 more source

